Regenerative Medicine Virtual Visit: The 6-Step Journey from Screen to Treatment Table

Introduction: Your Virtual Visit Is More Than a Scheduling Call

In 2024, over 116 million patients worldwide consulted with their doctor online—nearly double the approximately 57 million who did so in 2019. Regenerative medicine has emerged as one of the fastest-growing beneficiaries of this telehealth revolution, fundamentally changing how patients access cutting-edge orthopedic care.

A regenerative medicine virtual visit is not a booking formality or a simple scheduling call. It functions as a clinically meaningful triage event that determines a patient’s entire treatment trajectory. From the moment a patient connects via video to the day they receive their injection, every step follows a deliberate pathway designed to match the right treatment to the right candidate.

This article maps the complete 6-step journey from screen to treatment table: what happens during the video consultation, how candidacy is determined, what bridges the gap between virtual and in-person care, and what procedure day actually looks like. For patients navigating confusion about what can be accomplished virtually versus in person, uncertainty about qualification criteria, and questions about cost and insurance, this guide provides the clarity needed to make informed decisions.

Unicorn Bioscience exemplifies this hybrid care model, offering virtual consultations paired with eight in-person locations across Texas, Florida, and New York. This approach represents the future of regenerative medicine access—transparent, educational, and designed to empower patients with the knowledge they need at every stage.

What a Regenerative Medicine Virtual Visit Actually Is (And What It Isn’t)

A regenerative medicine virtual visit is a HIPAA-compliant, two-way video consultation with a licensed provider. During this session, patients discuss symptoms, medical history, imaging results, and treatment goals—all without requiring an initial in-person visit.

The critical distinction that many patients miss: the consultation is virtual-eligible, but the procedure is always in-person. No regenerative injection—whether PRP, stem cell, BMAC, or exosome therapy—can be administered remotely. The virtual visit serves as the gateway to treatment, not the treatment itself.

Patient misconceptions about regenerative medicine remain widespread. A Mayo Clinic study of 533 patients found that many held beliefs about stem cell therapy not supported by current medical evidence, underscoring why education during the virtual visit matters so significantly.

From a regulatory standpoint, the telehealth landscape supports this care model. The DEA has extended telehealth prescribing flexibilities through the end of 2026, and the Interstate Medical Licensure Compact (IMLC) is operational in 40 states plus Washington D.C. and Guam, enabling cross-state virtual consultations for qualified providers.

The market legitimacy of regenerative medicine for orthopedics continues to strengthen. The global regenerative medicine market was valued at approximately $51.65 billion in 2025 and is projected to exceed $63 billion by 2026, with orthopedics commanding 34.64% of that market. This is a rapidly maturing field with substantial clinical infrastructure—not a fringe offering.

Step 1 — Online Scheduling and Pre-Visit Intake

Before the video call begins, patients complete several preparatory steps: selecting an appointment slot, filling out digital intake forms covering medical history, current symptoms, medications, and prior treatments, and uploading a government-issued ID for identity verification.

The intake form serves a clinical purpose beyond administrative convenience. Providers review this information before the call to identify potential red flags—active cancer, blood disorders, or certain medications—that may affect candidacy. This pre-call review makes the video consultation itself more efficient and focused.

Many regenerative medicine clinics, including Unicorn Bioscience, offer a complimentary first consultation, framing this as a low-barrier, no-financial-commitment first step for patients exploring their options.

Patients should gather the following materials before scheduling:

• A complete list of current medications, especially NSAIDs and blood thinners
• Prior imaging such as X-rays and MRI reports
• A summary of treatments already attempted, including physical therapy and cortisone injections
• A clear description of the affected area and symptom timeline

Step 2 — The Video Call: What the Provider Is Doing in Real Time

Initial virtual consultations typically run 60 to 90 minutes—significantly longer than a standard telehealth visit. This extended duration exists because the provider conducts a structured clinical assessment, not just a conversation.

During the call, the provider works through a real-time decision tree covering multiple clinical activities:

• Symptom history and timeline review
• Prior treatment history and outcomes assessment
• Review of imaging or labs shared digitally on-screen
• Functional assessment questions regarding range of motion, weight-bearing capacity, and activity limitations
• Medication review for contraindications
• Patient goal-setting discussion

Advanced telehealth platforms allow physicians to display and annotate X-rays and MRI images during the call, transforming the virtual visit into a genuine diagnostic conversation rather than a phone intake.

The education component is equally important. Providers correct misinformation, explain what regenerative therapies can and cannot achieve, and set realistic outcome expectations. According to Mayo Clinic research, this educational function is central to responsible regenerative medicine consultation.

The Candidacy Decision Tree: How Providers Determine Qualification

Most clinic websites list vague candidacy criteria. Understanding the actual clinical logic helps patients self-assess before booking and sets appropriate expectations.

Primary candidacy factors include:

Diagnosis type: Osteoarthritis, tendon injuries, ligament tears, rotator cuff damage, meniscus injuries, and chronic joint pain represent the most common qualifying conditions.

Failure of conservative treatments: NSAIDs, cortisone injections, and physical therapy that have not produced adequate relief typically must be documented.

Imaging findings: X-ray and MRI results that confirm structural pathology without ruling out regenerative benefit.

Overall health status: Absence of active cancer, blood disorders, or severe systemic illness.

Age and biological factors: Inflammation levels, healing capacity, and current medications all influence candidacy.

Patient goals: Alignment between realistic therapeutic outcomes and patient expectations.

Disqualifying factors identified during the virtual visit include active malignancy, certain autoimmune conditions, anticoagulant therapy that cannot be paused, severe joint destruction beyond the therapeutic window, and unrealistic expectations that cannot be corrected through education.

Treatment modality matching follows from this assessment. Not every candidate receives the same therapy. The provider’s decision tree branches into PRP for early-stage conditions, BMAC or stem cell concentrate for moderate-to-severe osteoarthritis, exosome therapy for cellular signaling support, hyaluronic acid for joint lubrication, or combination protocols—each with different candidacy thresholds.

Unicorn Bioscience develops personalized regenerative medicine protocols based on inflammation levels, patient age, injury type and location, current medications, and personal health goals, illustrating how the decision tree produces individualized rather than one-size-fits-all recommendations.

Step 3 — Candidacy Determination and the Post-Visit Recommendation

Three possible outcomes emerge from a virtual visit:

1. Confirmed candidate: Proceed to imaging and documentation submission, then schedule the in-person procedure
2. Conditional candidate: Additional imaging or lab work needed before final determination
3. Not a current candidate: Referral to alternative care, lifestyle modification, or re-evaluation after conservative treatment

At the call’s conclusion, the provider communicates a verbal summary of findings, a recommended treatment modality with supporting rationale, required next steps, and a written follow-up summary sent to the patient.

Insurance realities require upfront acknowledgment. As of 2026, most major insurers—including Aetna, Cigna, and United Healthcare—classify PRP and stem cell injections as experimental and deny coverage. The virtual consultation may represent the most cost-effective first step before committing to out-of-pocket treatment costs.

Unicorn Bioscience maintains transparency on regulatory context: as of 2026, the FDA has not approved stem cell, PRP, or exosome products specifically for orthopedic conditions, but substantial clinical evidence supports safety and efficacy when administered by qualified providers within FDA regulatory frameworks.

Step 4 — The Documentation Bridge: Connecting the Virtual Visit to Procedure Day

The steps between a virtual consultation and an in-person procedure often remain unexplained. This documentation bridge typically includes:

Imaging requirements: Weight-bearing X-rays for joint assessment, MRI for soft tissue evaluation, and sometimes ultrasound imaging of the affected area. Patients may obtain these locally and upload them digitally.

Lab work requirements: BMAC and stem cell concentrate procedures may require a recent complete blood count and metabolic panel. PRP candidates may need platelet count verification.

Digital submission: Modern regenerative medicine platforms allow patients to upload imaging via secure patient portals, share DICOM files, or authorize electronic records transfer.

Unicorn Bioscience’s precision-guided injection technology requires all injections to be administered using ultrasound and X-ray guidance, meaning pre-procedure imaging directly informs the technical approach used on procedure day.

Step 5 — Scheduling and Preparing for the In-Person Procedure

Once documentation is confirmed, patients schedule their in-person appointment at the nearest clinic location. For qualified candidates whose imaging and documentation are already on file, the in-person visit can combine a brief physical examination and the procedure on the same day.

Pre-procedure preparation instructions typically include:

• Pausing NSAIDs for 5–7 days before PRP procedures
• Staying well-hydrated in the days before the procedure
• Avoiding corticosteroid injections for 4–6 weeks prior
• Bringing a current medication list
• Arranging transportation if needed

The in-person visit adds what the virtual visit cannot: physical palpation, real-time ultrasound assessment, confirmation of injection site anatomy, and hands-on clinical judgment. The provider arrives already knowing the patient’s history, imaging, goals, and planned treatment modality.

Step 6 — Procedure Day and the Post-Treatment Pathway

Procedure day follows a structured sequence: arrival, brief pre-procedure assessment, preparation of the treatment agent, imaging-guided injection, and post-procedure monitoring.

Unicorn Bioscience uses ultrasound and X-ray guidance for all injections, ensuring accurate delivery to targeted tissue—a technical standard that differentiates quality providers from those using unguided injection techniques.

Most patients are monitored briefly and can return home the same day. Unicorn Bioscience reports that more than 90% of stem cell patients have not gone on to knee replacement surgery, demonstrating the effectiveness of proper candidacy assessment and treatment planning.

Virtual follow-up appointments are well-suited for post-procedure monitoring—reviewing symptom progress, assessing functional improvement, and determining whether additional treatment cycles are warranted.

Who Is — and Isn’t — a Good Candidate: A Virtual Triage Guide by Condition

Osteoarthritis: Patients with mild-to-moderate osteoarthritis who have tried NSAIDs and physical therapy without adequate relief and have not yet had joint replacement surgery are typically strong candidates. Up to 80% of patients told they need total knee replacement may not actually require surgery.

Tendon injuries: When imaging confirms partial-thickness tendon damage and conservative treatment has failed, regenerative therapy—particularly PRP—has strong clinical support.

Ligament tears: Partial tears with intact joint stability may qualify; complete tears requiring mechanical reconstruction generally do not. Patients with cellular therapy for ligament tears may find this a viable non-surgical path.

Chronic spine pain: Facet joint arthritis, sacroiliac joint dysfunction, and disc-related pain may respond to regenerative approaches when the pain generator is accessible to injection.

Who is not a current candidate: Patients with end-stage joint destruction, active infection or malignancy, certain blood disorders, or unrealistic expectations. A responsible provider identifies these during the virtual visit—not after payment.

Conclusion: The Virtual Visit as the Starting Line, Not the Finish Line

A regenerative medicine virtual visit is not a scheduling formality—it is the clinical event that sets the entire treatment trajectory. The 6-step journey moves from online scheduling and intake through the clinical video consultation, candidacy determination, documentation bridge, in-person procedure scheduling, and finally procedure day with post-treatment follow-up.

For patients navigating regenerative medicine, a transparent, education-first virtual consultation with a qualified provider offers the most efficient path through the complexity of marketing claims, regulatory context, and insurance ambiguity.

The global regenerative medicine market continues its rapid expansion, with orthopedics representing the largest application segment. For the right candidate, the virtual visit marks the first step toward a non-surgical path that the majority of patients successfully complete.

Schedule a Virtual Consultation with Unicorn Bioscience

Patients interested in exploring regenerative medicine options can schedule a complimentary virtual consultation with Unicorn Bioscience—a first step carrying no financial commitment and no obligation.

Unicorn Bioscience offers virtual consultations paired with eight in-person locations across Texas (Austin, Dallas, El Paso, Fort Worth, Houston, San Antonio), Florida (Boca Raton), and New York (Manhattan), providing geographic convenience for patients across multiple states.

Contact: (737) 347-0446 or visit unicornbioscience.com to schedule.

Consultations are conducted by a qualified medical team—including providers with training from Johns Hopkins—within FDA regulatory frameworks, with personalized treatment planning based on each patient’s specific condition, imaging, and goals. More than 90% of stem cell patients have not gone on to knee replacement surgery, demonstrating the effectiveness of proper candidacy assessment from the very first virtual visit.